LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

Search

Celldex Therapeutics Inc

Fechado

SetorSaúde

24.49 0.25

Visão Geral

Variação de preço das ações

24h

Atual

Mín

24

Máximo

24.8

Indicadores-chave

By Trading Economics

Rendimento

-2.8M

-57M

Vendas

35K

730K

Margem de lucro

-7,753.425

Funcionários

186

EBITDA

-1.1M

-63M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+113.8% upside

Dividendos

By Dow Jones

Próximos Ganhos

4 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

107M

1.6B

Abertura anterior

24.24

Fecho anterior

24.49

Sentimento de Notícias

By Acuity

21%

79%

48 / 371 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Celldex Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de set. de 2025, 22:39 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15 de set. de 2025, 16:43 UTC

Grandes Movimentos do Mercado

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15 de set. de 2025, 16:42 UTC

Grandes Movimentos do Mercado

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15 de set. de 2025, 16:35 UTC

Grandes Movimentos do Mercado

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15 de set. de 2025, 23:46 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 de set. de 2025, 23:46 UTC

Conversa de Mercado

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15 de set. de 2025, 23:34 UTC

Conversa de Mercado

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15 de set. de 2025, 22:48 UTC

Conversa de Mercado

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15 de set. de 2025, 22:12 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL Expects Commercial Launch in 2029

15 de set. de 2025, 22:12 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15 de set. de 2025, 22:11 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15 de set. de 2025, 22:11 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL to Have Right to Exercise Option Based on Phase 3 Data

15 de set. de 2025, 22:10 UTC

Aquisições, Fusões, Aquisições de Empresas

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15 de set. de 2025, 21:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15 de set. de 2025, 21:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15 de set. de 2025, 21:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15 de set. de 2025, 21:14 UTC

Aquisições, Fusões, Aquisições de Empresas

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15 de set. de 2025, 20:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

15 de set. de 2025, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

15 de set. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

15 de set. de 2025, 19:29 UTC

Conversa de Mercado

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15 de set. de 2025, 19:14 UTC

Conversa de Mercado

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15 de set. de 2025, 18:16 UTC

Conversa de Mercado

Gold Powers to New High -- Market Talk

15 de set. de 2025, 18:05 UTC

Conversa de Mercado

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15 de set. de 2025, 17:50 UTC

Aquisições, Fusões, Aquisições de Empresas

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15 de set. de 2025, 17:10 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 de set. de 2025, 17:10 UTC

Conversa de Mercado

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15 de set. de 2025, 16:52 UTC

Conversa de Mercado

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15 de set. de 2025, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

15 de set. de 2025, 16:20 UTC

Conversa de Mercado
Ganhos

Auto & Transport Roundup: Market Talk

Comparação entre Pares

Variação de preço

Celldex Therapeutics Inc Previsão

Preço-alvo

By TipRanks

113.8% parte superior

Previsão para 12 meses

Média 52.38 USD  113.8%

Máximo 67 USD

Mínimo 38 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Celldex Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

10 ratings

10

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

18.91 / 20.63Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

48 / 371 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
help-icon Live chat